Make evidence based decisions that complement your feasibility assumptions or cross-examine third party proposals.
Emerging markets and the complexity of many new treatment scenarios has intensified rivalry for clinical centres. Coupled to this, portfolio diversification often requires companies initiating studies beyond their traditional boundaries or outside their therapeutic comfort zone. The challenge is to liaise with local stakeholders and engineer project success with reliable information. ta-Scan verifies your territories choices and partners. We can help identify individuals or an organization with a specific research pedigree in your chosen country and rank these against alternative country options.
Get a global view; understand the competitive landscape and health policies that support your life-cycle strategies. Analyze and model with accurate pipeline data and regional standards of care. ta-scan has developed many graphic treatments tuned for today’s information hungry executive. Updated regularly, a profile of your therapy areas can be generated to produce custom reports.